The Effect of Chronic Periodontitis on Serum Levels of Tumor Necrosis Factor-alpha in Alzheimer Disease

Overview

Journal Dent Res J (Isfahan)

Specialty Dentistry

Date 2014 Nov 27

PMID 25426144

Citations 28

Authors

Shirin Zahra Farhad

Shahram Amini

Amir Khalilian

Majid Barekatain

Morvarid Mafi

Mehrdad Barekatain

Ehsan Rafei

Affiliations

Soon will be listed here.

Abstract

Background: Despite the outbreak in dental science, oral and dental complications in Alzheimer are of the unsolved problems. It is assumed that tumor necrosis factor-α, which is a key factor in Alzheimer, has a relation with periodontal complications in patients with Alzheimer disease. The present study evaluated the effect of chronic periodontitis on serum levels of tumor necrosis factor-α in Alzheimer disease.

Materials And Methods: This case-control study was performed on 80 patients with Alzheimer disease seeking medical care at Nour Hospital, Isfahan, Iran. Eighty patients with Alzheimer disease between 40 and 70 years old attended this study. Forty had chronic periodontitis (case group), and 40 patients had healthy periodontium (control group). Blood sample was taken, and serum levels of tumor necrosis factor-α were measured by means of an ELISA Reader device. Independent T-Test was used to analyze data, and P < 0.05 was considered significant.

Results: The mean of tumor necrosis factor-α was 749.1 ng/μL in case group and 286.8 ng/μL in control group. Independent t-test showed that the mean of tumor necrosis factor-α in patients with Alzheimer and periodontitis was approximately three folds higher than the patients only with Alzheimer, and this difference was statistically significant (P < 0.001).

Conclusion: According to the results of this study, it seems that there is a difference between serum levels of tumor necrosis factor-α in patient with Alzheimer and chronic periodontitis and patients with Alzheimer disease and healthy periodontium. Tumor necrosis factor-α level in serum may act as a diagnostic marker of periodontal disease in patients with Alzheimer disease.

Citing Articles

Exploring the Link Between Periodontitis and Alzheimer's Disease-Could a Nanoparticulate Vaccine Break It?.

Ferreira da Silva A, Gomes A, Goncalves L, Fernandes A, Almeida A Pharmaceutics. 2025; 17(2).

PMID: 40006510 PMC: 11858903. DOI: 10.3390/pharmaceutics17020141.

Can salivary and skin microbiome become a biodetector for aging-associated diseases? Current insights and future perspectives.

Nurkolis F, Utami T, Alatas A, Wicaksono D, Kurniawan R, Ratmandhika S Front Aging. 2024; 5:1462569.

PMID: 39484071 PMC: 11524912. DOI: 10.3389/fragi.2024.1462569.

Correlation study of periodontitis with cognitive impairment.

Tao Y, He M, Hu H, Gao Z, Huang Z, Li H Hua Xi Kou Qiang Yi Xue Za Zhi. 2024; 40(5):549-553.

PMID: 38596975 PMC: 9588862. DOI: 10.7518/hxkq.2022.05.007.

Oral Health as a Risk Factor for Alzheimer Disease.

Pruntel S, van Munster B, de Vries J, Vissink A, Visser A J Prev Alzheimers Dis. 2024; 11(1):249-258.

PMID: 38230738 PMC: 10994994. DOI: 10.14283/jpad.2023.82.

Effect of Periodontal Disease on Alzheimer's Disease: A Systematic Review.

Bouziane A, Lattaf S, Abdallaoui Maan L Cureus. 2023; 15(10):e46311.

PMID: 37916259 PMC: 10616904. DOI: 10.7759/cureus.46311.

References

Chiarini A, Dal Pra I, Whitfield J, Armato U . The killing of neurons by beta-amyloid peptides, prions, and pro-inflammatory cytokines. Ital J Anat Embryol. 2007; 111(4):221-46. View

Alvarez A, Cacabelos R, Sanpedro C, Garcia-Fantini M, Aleixandre M . Serum TNF-alpha levels are increased and correlate negatively with free IGF-I in Alzheimer disease. Neurobiol Aging. 2006; 28(4):533-6. DOI: 10.1016/j.neurobiolaging.2006.02.012. View

Gemmell E, Marshall R, Seymour G . Cytokines and prostaglandins in immune homeostasis and tissue destruction in periodontal disease. Periodontol 2000. 1997; 14:112-43. DOI: 10.1111/j.1600-0757.1997.tb00194.x. View

Fillit H, Ding W, Buee L, Kalman J, Altstiel L, Lawlor B . Elevated circulating tumor necrosis factor levels in Alzheimer's disease. Neurosci Lett. 1991; 129(2):318-20. DOI: 10.1016/0304-3940(91)90490-k. View

Mohaddes Ardebili S, Yeghaneh T, Gharesouran J, Rezazadeh M, Farhoudi M, Ayromlou H . Genetic association of TNF-α-308 G/A and -863 C/A polymorphisms with late onset Alzheimer's disease in Azeri Turk population of Iran. J Res Med Sci. 2012; 16(8):1006-13. PMC: 3263076. View

Zou J, Crews F . TNF alpha potentiates glutamate neurotoxicity by inhibiting glutamate uptake in organotypic brain slice cultures: neuroprotection by NF kappa B inhibition. Brain Res. 2005; 1034(1-2):11-24. DOI: 10.1016/j.brainres.2004.11.014. View

Meme W, Calvo C, Froger N, Ezan P, Amigou E, Koulakoff A . Proinflammatory cytokines released from microglia inhibit gap junctions in astrocytes: potentiation by beta-amyloid. FASEB J. 2006; 20(3):494-6. DOI: 10.1096/fj.05-4297fje. View

Kamer A, Craig R, Dasanayake A, Brys M, Glodzik-Sobanska L, de Leon M . Inflammation and Alzheimer's disease: possible role of periodontal diseases. Alzheimers Dement. 2008; 4(4):242-50. DOI: 10.1016/j.jalz.2007.08.004. View

Tobinick E . Perispinal etanercept for treatment of Alzheimer's disease. Curr Alzheimer Res. 2008; 4(5):550-2. DOI: 10.2174/156720507783018217. View

10.

Pickering M, Cumiskey D, OConnor J . Actions of TNF-alpha on glutamatergic synaptic transmission in the central nervous system. Exp Physiol. 2005; 90(5):663-70. DOI: 10.1113/expphysiol.2005.030734. View

11.

Kamer A, Craig R, Pirraglia E, Dasanayake A, Norman R, Boylan R . TNF-alpha and antibodies to periodontal bacteria discriminate between Alzheimer's disease patients and normal subjects. J Neuroimmunol. 2009; 216(1-2):92-7. PMC: 2783848. DOI: 10.1016/j.jneuroim.2009.08.013. View

12.

Csiszar A, Labinskyy N, Smith K, Rivera A, Orosz Z, Ungvari Z . Vasculoprotective effects of anti-tumor necrosis factor-alpha treatment in aging. Am J Pathol. 2007; 170(1):388-98. PMC: 1762698. DOI: 10.2353/ajpath.2007.060708. View

13.

Ramos E, Lin M, Larson E, Maezawa I, Tseng L, Edwards K . Tumor necrosis factor alpha and interleukin 10 promoter region polymorphisms and risk of late-onset Alzheimer disease. Arch Neurol. 2006; 63(8):1165-9. DOI: 10.1001/archneur.63.8.1165. View

14.

Nonnenmacher C, Dalpke A, Zimmermann S, Flores-de-Jacoby L, Mutters R, Heeg K . DNA from periodontopathogenic bacteria is immunostimulatory for mouse and human immune cells. Infect Immun. 2003; 71(2):850-6. PMC: 145359. DOI: 10.1128/IAI.71.2.850-856.2003. View

15.

Tobinick E, Gross H . Rapid cognitive improvement in Alzheimer's disease following perispinal etanercept administration. J Neuroinflammation. 2008; 5:2. PMC: 2211476. DOI: 10.1186/1742-2094-5-2. View

16.

Medeiros R, Prediger R, Passos G, Pandolfo P, Duarte F, Franco J . Connecting TNF-alpha signaling pathways to iNOS expression in a mouse model of Alzheimer's disease: relevance for the behavioral and synaptic deficits induced by amyloid beta protein. J Neurosci. 2007; 27(20):5394-404. PMC: 6672347. DOI: 10.1523/JNEUROSCI.5047-06.2007. View

17.

Tarkowski E, Blennow K, Wallin A, Tarkowski A . Intracerebral production of tumor necrosis factor-alpha, a local neuroprotective agent, in Alzheimer disease and vascular dementia. J Clin Immunol. 1999; 19(4):223-30. DOI: 10.1023/a:1020568013953. View

18.

Macuch P, Tanner A . Campylobacter species in health, gingivitis, and periodontitis. J Dent Res. 2000; 79(2):785-92. DOI: 10.1177/00220345000790021301. View

19.

Takeuchi H, Jin S, Wang J, Zhang G, Kawanokuchi J, Kuno R . Tumor necrosis factor-alpha induces neurotoxicity via glutamate release from hemichannels of activated microglia in an autocrine manner. J Biol Chem. 2006; 281(30):21362-21368. DOI: 10.1074/jbc.M600504200. View

20.

Lio D, Annoni G, Licastro F, Crivello A, Forte G, Scola L . Tumor necrosis factor-alpha -308A/G polymorphism is associated with age at onset of Alzheimer's disease. Mech Ageing Dev. 2006; 127(6):567-71. DOI: 10.1016/j.mad.2006.01.015. View